Clinical Investigation

Kidney International (1993) 43, 903–911; doi:10.1038/ki.1993.127

Adsorption of complement factor D by polyacrylonitrile dialysis membranes

Manuel Pascual1 and Jürg A Schifferli1

1Laboratoire d'Immunonéphrologie, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland

Correspondence: Dr M Pascual MD, Laboratoire d'Immunonéphrologie, 5.222, Centre Médical Universitaire, 1211 Genéve 4, Switzerland.

Received 2 August 1992; Revised 26 October 1992; Accepted 26 October 1992.

Top

Abstract

Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Factor D, an essential enzyme of the alternative pathway (AP) of complement, accumulates in end-stage renal failure (ESRF). Polyacrylonitrile (PAN) membrane activates complement poorly and has been shown to adsorb C3a, the main anaphylatoxin released during complement activation. In the present work we investigated whether factor D might be adsorbed on PAN. In vitro there was a loss of hemolytic factor D when normal human serum (NHS) was incubated with PAN dialysis fibers, whereas no loss was observed with cuprophan (Cu) fibers. There was a dose and time dependent binding of purified radiolabeled factor D to PAN but not to Cu. The hemolytic function of factor D released from PAN by 2 M NaCl was normal. By contrast, factor D was inactive while adsorbed to PAN fibers. When 50 ml of NHS or 100 ml of whole blood were passed through a new hollow fiber PAN dialyzer 95% of factor D was adsorbed. The eluate from a PAN filter which had been used for dialysis in a patient with ESRF contained 38.4 mg of hemolytic factor D, representing 34% of the proteins eluted. By immunoblotting, antigenic factor D from the PAN eluate was identical to purified human factor D. In six patients there was a 81.4% decrease in hemolytic factor D in blood after dialysis with PAN, contrasting with a 9.6% decrease in those dialyzed with cellulose acetate. No factor D was found in the dialysis fluid of PAN dialyzers, indicating that PAN removed factor D mainly by adsorption. In conclusion, PAN has a significant capacity to adsorb factor D, a reaction that might contribute to the diminished capacity of PAN membrane to activate the AP of complement. Whether the efficient removal of large amounts of factor D might be beneficial in uremic patients remains to be defined.

Abbreviations:

AP, Alternative pathway; CA, Cellulose acetate; CVF, Cobra venom factor; Cu, Cuprophan; ESRF, End-stage renal failure; PAN, Polyacrylonitrile; RD, Normal serum immunochemically depleted of factor D; SDS-PAGE, Sodium dodecylsulfate polyacrylamide gel electrophoresis; VBS++, Veronal buffered saline

Top

References

  1. Schulman G, Hakim RM: Recent advances in the biocompatibility of haemodialysis membranes. Nephrol Dial Transplant 6 (Suppl 2):10–13, 1991
  2. Hakim RM, Schafer AI: Hemodialysis associated platelet activation and thrombocytopenia. Am J Med 78:575–580, 1985 | Article | PubMed | ISI | ChemPort |
  3. Hakim RM, Breillat J, Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878–882, 1984 | PubMed | ISI | ChemPort |
  4. Hakim RM, Fearon DT, Lazarus JM: Biocompatibility of dialysis membranes: Effects of chronic complement activation. Kidney Int 26:194–200, 1984 | PubMed | ISI | ChemPort |
  5. Chenoweth DE, Cheung AK, Henderson LW: Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 24:764–769, 1983 | PubMed | ChemPort |
  6. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leucocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296:769–774, 1977 | PubMed | ISI | ChemPort |
  7. Ivanovich P, Chenoweth DE, Schmidt R, Klinkmann H, Boxer LA, Jacob HS, Hammerschmidt DE: Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 24:758–763, 1983
  8. Janatova J, Cheung AK, Parker CJ: Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 8:61–69, 1991
  9. Cheung AK, Parker CJ, Wilcox L, Janatova J: Activation of the alternative pathway of complement by cellulosic hemodialysis membranes. Kidney Int 36:257–265, 1989 | PubMed | ISI | ChemPort |
  10. Kazatchkine MD, Carreno MP: Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 9:30–35, 1988
  11. Carreno MP, Labarre D, Maillet F, Jozefowicz M, Kazatchkine MD: Regulation of the human alternative complement pathway: Formation of a ternary complex between factor H, surface bound C3b and chemical groups on non-activating surfaces. Eur J Immunol 19:2145–2150, 1989
  12. Carreno MP, Labarre D, Jozefowicz M, Kazatchkine MD: The ability of sephadex to activate human complement is suppressed in specifically substituted functional sephadex derivatives. Mol Immunol 25:165–171, 1988
  13. Carreno MP, Maillet F, Labarre D, Jozefowicz M, Kazatchkine MD: Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. Biomaterials 9:514–518, 1988
  14. Maillet F, Kazatchkine MD: Specific antibodies enhance alternative complement pathway activation by cuprophan. Nephrol Dial Transplant 6:193–197, 1991 | PubMed |
  15. Cheung AK, Chenoweth DE, Otsuka D, Henderson LW: Compartmental distribution of complement activation products in artificial kidneys. Kidney Int 30:74–80, 1986 | PubMed | ISI | ChemPort |
  16. Goldman M, Dhaene M, Vanherweghem J-L: Removal of beta2-microglobulin by adsorption on dialysis membranes. Nephrol Dial Transplant 2:576–577, 1987
  17. Zingraff J, Beyne P, Urena M, Uzan M, Nguyen Khoa M, Descamps-Latscha B, Drueke T: Influence of hemodialysis membranes on beta2-microglobulin kinetics: In vivo and in vitro studies. Nephrol Dial Transplant 3:284–290, 1988 | PubMed | ChemPort |
  18. Koch KM: Dialysis-related amyloidosis. Kidney Int 41:1416–1429, 1992 | PubMed | ISI | ChemPort |
  19. Laude-Sharp M, Caroff M, Simard L, Pusineri C, Kazatchkine M, Haeffner-Cavaillon N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS). Kidney Int 38:1089–1094, 1990 | PubMed | ChemPort |
  20. Lonemann G, Koch KM, Shaldon S, Dinarello CA: Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med 112:76–86, 1988
  21. Amadori A, Candi P, Sasdelli M, Massai G, Favilla S, Passaleva A, Ricci M: Hemodialysis leukopenia and complement function with different dialyzers. Kidney Int 24:775–781, 1983
  22. Cheung AK: Adsorption of unactivated complement proteins by hemodialysis membranes. Am J Kidney Dis 14:472–477, 1989
  23. Cheung AK, Parker CJ, Wilcox LA, Janatova J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidney Int 37:1055–1059, 1990 | PubMed | ISI | ChemPort |
  24. Moore B, Walsh J, Schulman G, Arbeit L: Polyacrylonitrile dialysis membranes scavenge C3a desArg in man. (abstract) Kidney Int 35:256, 1989
  25. Volanakis JE: Participation of C3 and its ligands in complement activation, in Current Topics in Microbiology and Immunology (153: The Third Component of Complement), edited by Lambris JD, Berlin, Springer Verlag, 1989, p. 1
  26. Lesavre PH, Müller-Eberhard HJ: Mechanism of action of factor D of the alternative complement pathway. J Exp Med 148:1498–1509, 1978 | Article | PubMed | ISI | ChemPort |
  27. Volanakis JE, Barnum SR, Giddens M, Galla JH: Renal filtration and catabolism of complement protein D. N Engl J Med 312:395–399, 1985 | PubMed | ISI | ChemPort |
  28. Sturfelt G, Keller C, Truedsonn L, Thysell H: Complement factor D in serum. Scand J Rheum 14:315–317, 1985
  29. Pascual M, Steiger G, Estreicher J, MacOn K, Volanakis JE, Schifferli JA: Metabolism of complement factor D in renal failure. Kidney Int 34:529–536, 1988 | PubMed | ISI | ChemPort |
  30. Pascual M, Paccaud JP, MacOn K, Volanakis JE, Schifferli JA: Complement activation by the alternative pathway is modified in renal failure: The role of factor D. Clin Nephrol 32:185–193, 1989 | PubMed | ISI | ChemPort |
  31. Catana E, Schifferli JA: Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis. J Immunol Meth 138:265–271, 1991
  32. Bolton AE, Hunter WM: The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J 133:529–539, 1973 | PubMed | ISI | ChemPort |
  33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685, 1970 | Article | PubMed | ISI | ChemPort |
  34. Pascual M, Catana E, Spertini F, MacOn K, Volanakis JE, Schifferli JA: A monoclonal antibody which blocks the function of factor D of human complement. J Immunol Meth 127:263–269, 1990
  35. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies. Anal Biochem 15:45–52, 1966 | Article | PubMed | ISI | ChemPort |
  36. Wegmüller E, Montandon A, Nydegger U, Descoeudres C: Biocompatibility of different hemodialysis membranes: Activation of complement and leucopenia. Int J Artif Organ 9:85–92, 1986
  37. Pertosa G, Tarantino EA, Marfella C, Gesualdo L, Schena FP: Effect of different hemodialysis procedures on C5b-9 generation. (abstract) Complement Inflamm 8:209, 1991
  38. Volanakis JE, MacOn KM: Isolation of complement protein D from urine of patients with Fanconi's syndrome. Anal Biochem 163:242–246, 1987
  39. Oppermann M, Haubitz M, Quentin E, Götze O: Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B. Klin Wochenschr 66:857–864, 1988
  40. Oppermann M, Kurts C, Zierz R, Quentin E, Weber MH, Götze O: Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure. Kidney Int 40:939–947, 1991 | PubMed |

Extra navigation

.
ADVERTISEMENT